Flibanserin (BIMT-17; BIMT-17BS; EBD-6396; Girosa; trade name Addyi) is a novel and potent agonist of the 5-HT1A and serotonergic antidepressant approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). The medication increases the number of satisfying sexual events per month by about one half over placebo from a starting point of about two to three.

纯度：≥98%

CAS：167933-07-5